US Broker Ratings

Precigen, Inc. (PGEN) Stock Analysis: Unpacking the 100% Upside Potential

In the ever-evolving world of biotechnology, Precigen, Inc. (NASDAQ: PGEN) stands out as a compelling player, particularly with its ambitious focus on gene and cell therapies..

Abivax SA (ABVX) Stock Analysis: Eyeing a 37.93% Potential Upside, All Eyes on Phase 3 Trials

Abivax SA (ABVX), a Paris-based biotechnology firm, is capturing significant investor interest with its promising drug pipeline and a compelling 37.93% potential upside. While the company..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 44.67% Potential Upside in the Pediatric Orthopedic Market

OrthoPediatrics Corp. (NASDAQ: KIDS) represents a unique player in the healthcare sector, specifically within the medical devices industry. This Indiana-based company is dedicated to addressing the..

Inventiva S.A. (IVA) Stock Analysis: Exploring a 166.96% Potential Upside with Exciting Biotech Developments

Inventiva S.A. (IVA), a dynamic player in the biotechnology sector, is capturing investor attention with its cutting-edge pursuits in treating metabolic and rare diseases. Headquartered in..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring the 770% Potential Upside in Revolutionary Biotechnology

Humacyte, Inc. (NASDAQ: HUMA), a trailblazer in the biotechnology sector, is making waves with its innovative approach to bioengineered human tissues. As the company pioneers advanced..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Exploring a Promising 148.86% Upside in Biotech

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical firm, is currently catching the eye of investors with a compelling potential upside of 148.86%, according to recent..

Maze Therapeutics, Inc. (MAZE): Investor Outlook on Strong Buy Ratings and 12.50% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector with its innovative approach to developing small molecule precision..

PureTech Health plc (PRTC) Stock Analysis: Unpacking the Remarkable 542.70% Revenue Growth

For investors with an eye on the biotechnology sector, PureTech Health plc (NASDAQ: PRTC) presents a compelling case with its exceptional revenue growth metrics and diverse..

Autolus Therapeutics plc (AUTL) Stock Analysis: A Biotech Gem with 606% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based clinical-stage biopharmaceutical company, is grabbing attention in the healthcare sector with its promising pipeline of T cell therapies targeting..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 129% Potential Upside Amidst Promising Revenue Growth

For investors seeking opportunities in the healthcare sector, Organogenesis Holdings Inc. (NASDAQ: ORGO) presents an intriguing proposition. With its focus on regenerative medicine, the company is..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 62% Potential Upside in Healthcare

Kamada Ltd. (NASDAQ: KMDA), a specialty and generic drug manufacturer headquartered in Israel, is attracting significant attention from investors. With a focus on plasma-derived protein therapeutics,..

Prothena Corporation plc (PRTA) Stock Analysis: 143.51% Potential Upside with Cutting-Edge Biotechnology Innovations

Prothena Corporation plc (NASDAQ: PRTA), a Dublin-based biotechnology company, is making waves in the healthcare sector with its promising pipeline of novel therapies aimed at tackling..

Weave Communications, Inc. (WEAV) Stock Analysis: 71% Potential Upside with Strong Buy Ratings

For investors seeking opportunities in the healthcare technology sector, Weave Communications, Inc. (WEAV) presents a compelling case. Specializing in health information services, Weave Communications offers a..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 92% Potential Upside for Investors

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, is renowned for its innovative contributions to medical technology. Specializing in medical instruments and supplies,..

Cel-Sci Corporation (CVM) Investor Outlook: Analyzing the 767% Potential Upside in Biotech Innovation

In the fast-evolving world of biotechnology, Cel-Sci Corporation (CVM) stands as an intriguing prospect for investors. With a focus on harnessing the power of the immune..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Exploring a 59% Potential Upside in the Diagnostics Space

For investors seeking opportunities in the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents a compelling case. This US-based molecular diagnostics company, with a market cap..

Celcuity Inc. (CELC) Stock Analysis: Exploring a 5.96% Potential Upside in the Biotechnology Sector

Celcuity Inc. (NASDAQ: CELC), a prominent player in the biotechnology sector, is drawing investor attention with its promising drug development initiatives and a notable potential upside..

Butterfly Network, Inc. (BFLY): Investor Outlook on a 56.73% Potential Upside

Butterfly Network, Inc. (BFLY), a pioneer in the healthcare sector, is making waves with its innovative medical devices, particularly in the ultrasound imaging domain. Known for..

CeriBell, Inc. (CBLL) Stock Analysis: 45.52% Potential Upside with Strong Buy Ratings in Medical Devices Sector

CeriBell, Inc. (CBLL), a U.S.-based medical technology company, is making waves in the healthcare sector with its innovative solutions for the diagnosis and management of serious..

AtaiBeckley Inc. (ATAI): Biotech Stock with a Staggering 265% Potential Upside and Strong Buy Ratings

AtaiBeckley Inc. (ATAI), a dynamic player in the biotechnology sector, is capturing investor attention with its substantial growth potential and an impressive 265.24% potential upside, according..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds